HAL (France)open access
Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience
Advance combined treatment, 0, 2, Inflammatory bowel diseases, 1, Selective JAK1 inhibitors, Drug safety, Biologics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 261986
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.